WILEX AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13149
 
  
 
C07K PEPTIDES 6130
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0002,350 CAIX STRATIFICATION BASED ON CANCER TREATMENTFeb 21, 14Jan 07, 16[G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
RE46424 Method for producing 3-amidinophenylalanine derivativesDec 31, 13Jun 06, 17[C07D]
9605075 Hybridoma cell line G250 and its use for producing monoclonal antibodiesDec 23, 08Mar 28, 17[A61K, C07K]
9089532 Stable dosage form of phenylalanine derivativesSep 20, 05Jul 28, 15[A61K]
8828381 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomasSep 15, 09Sep 09, 14[A61K, C07K]
8642761 Method for producing 3-amidinophenylalanine derivativesNov 18, 11Feb 04, 14[C07D, C07C]
8492385 Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereofMar 29, 10Jul 23, 13[A61K, C07D]
8492520 Binding epitopes for G250 antibodyOct 31, 08Jul 23, 13[C07K]
8093258 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseasesJun 22, 06Jan 10, 12[A61K, A01N]
8088921 Method for producing 3-amidinophenylalanine derivativesOct 15, 10Jan 03, 12[C07D]
7951589 Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptorMar 10, 06May 31, 11[C12P, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0017,252 BINDING EPITOPES FOR G250 ANTIBODYAbandonedJul 01, 13Jan 16, 14[C07K]
8461321 Nucleic acids encoding a deletion variant of uPARExpiredJun 30, 08Jun 11, 13[C07H, C12Q, C12N]
2012/0207,672 SELECTIVE DETECTION OF BONE METASTASES IN RENAL CLEAR CELL CARCINOMAAbandonedSep 15, 10Aug 16, 12[A61K, C07K]
2012/0165,287 COMBINED TREATMENT OF CANCER BY UROKINASE INHIBITION AND A CYTOSTATIC ANTI-CANCER AGENT FOR ENHANCING THE ANTI-METASTATIC EFFECTAbandonedMar 02, 12Jun 28, 12[A61K, A61P]
2010/0068,272 HYDROXYAMIDINE AND HYDROXYGUANIDINE COMPOUNDS AS UROKINASE INHIBITORSAbandonedSep 14, 09Mar 18, 10[A61K, C07D, C07C, A61P]
2009/0286,837 Oxadiazole compounds as urokinase inhibitorsAbandonedAug 29, 06Nov 19, 09[A61K, C07D, C07C, A61P]
2008/0226,624 Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effectAbandonedMar 07, 08Sep 18, 08[A61K, A61P]
2008/0138,275 Hybridoma cell line G250 and its use for producing monoclonal antibodiesAbandonedJan 19, 07Jun 12, 08[A61K, C12P, C12N, A61P]
7208521 Selective inhibitors of the urokinase plasminogen activatorExpiredFeb 16, 05Apr 24, 07[A61K]
2006/0189,689 Arginine mimetics as factor Xa inhibitorsAbandonedApr 10, 06Aug 24, 06[A61K, C07C]
7049344 Highly selective inhibitors of the urokinase plasminogen activatorExpiredNov 22, 04May 23, 06[A61K]
7049460 Selective inhibitors of the urokinase plasminogen activatorExpiredAug 23, 00May 23, 06[C07C]
7038074 Arginine mimetics as factor X.sub.a inhibitorsExpiredFeb 09, 01May 02, 06[C07C]
2005/0181,034 Formulation of liposomal derivatives of phenylalanineAbandonedJan 21, 05Aug 18, 05[A61K]
6906032 Cyclic peptidomimetic urokinase receptor antagonistsExpiredJul 19, 00Jun 14, 05[A61K]
6872702 Inhibitors for urokinase receptorExpiredJan 07, 00Mar 29, 05[A61K]
6841702 Highly selective inhibitors of the urokinase plasminogen activatorExpiredSep 20, 02Jan 11, 05[C07C]
2004/0266,766 Selective urokinase inhibitorsAbandonedJun 14, 04Dec 30, 04[A61K]
2004/0219,633 Method of producing recombinant antibodiesAbandonedAug 07, 03Nov 04, 04[A61K, C07H, C12N, C07K]
2004/0138,110 Inhibitors of the urokinase receptorAbandonedJan 14, 04Jul 15, 04[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.